rs141010212
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001292063.2(OTOG):c.2398G>A(p.Asp800Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000478 in 1,550,332 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001292063.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.2398G>A | p.Asp800Asn | missense_variant | 20/56 | ENST00000399397.6 | NP_001278992.1 | |
OTOG | NM_001277269.2 | c.2434G>A | p.Asp812Asn | missense_variant | 19/55 | NP_001264198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.2398G>A | p.Asp800Asn | missense_variant | 20/56 | 5 | NM_001292063.2 | ENSP00000382329 | P2 | |
OTOG | ENST00000399391.7 | c.2434G>A | p.Asp812Asn | missense_variant | 19/55 | 5 | ENSP00000382323 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00265 AC: 404AN: 152238Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.000572 AC: 85AN: 148710Hom.: 0 AF XY: 0.000401 AC XY: 32AN XY: 79892
GnomAD4 exome AF: 0.000242 AC: 338AN: 1397976Hom.: 2 Cov.: 33 AF XY: 0.000210 AC XY: 145AN XY: 689466
GnomAD4 genome AF: 0.00265 AC: 403AN: 152356Hom.: 2 Cov.: 33 AF XY: 0.00252 AC XY: 188AN XY: 74488
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2022 | OTOG: BP4 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 02, 2020 | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 25, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 25, 2017 | p.Asp812Asn in exon 19 of OTOG: This variant is not expected to have clinical si gnificance because it has been identified in 1.0% (184/17160) of African chromos omes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.or g; dbSNP rs141010212). - |
OTOG-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at